These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 33166625)

  • 1. Adding insult to injury - Inflammation at the heart of cardiac fibrosis.
    Smolgovsky S; Ibeh U; Tamayo TP; Alcaide P
    Cell Signal; 2021 Jan; 77():109828. PubMed ID: 33166625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
    Frangogiannis NG
    Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis.
    Baci D; Bosi A; Parisi L; Buono G; Mortara L; Ambrosio G; Bruno A
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPV4 deletion protects heart from myocardial infarction-induced adverse remodeling via modulation of cardiac fibroblast differentiation.
    Adapala RK; Kanugula AK; Paruchuri S; Chilian WM; Thodeti CK
    Basic Res Cardiol; 2020 Jan; 115(2):14. PubMed ID: 31925567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
    Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
    J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling.
    Bujak M; Ren G; Kweon HJ; Dobaczewski M; Reddy A; Taffet G; Wang XF; Frangogiannis NG
    Circulation; 2007 Nov; 116(19):2127-38. PubMed ID: 17967775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis.
    Molkentin JD; Bugg D; Ghearing N; Dorn LE; Kim P; Sargent MA; Gunaje J; Otsu K; Davis J
    Circulation; 2017 Aug; 136(6):549-561. PubMed ID: 28356446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies aggravate the development of ischemic heart failure.
    Keppner L; Heinrichs M; Rieckmann M; Demengeot J; Frantz S; Hofmann U; Ramos G
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1358-H1367. PubMed ID: 30095974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast contributions to ischemic cardiac remodeling.
    Burke RM; Burgos Villar KN; Small EM
    Cell Signal; 2021 Jan; 77():109824. PubMed ID: 33144186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.
    de Kleijn DPV; Chong SY; Wang X; Yatim SMJM; Fairhurst AM; Vernooij F; Zharkova O; Chan MY; Foo RSY; Timmers L; Lam CSP; Wang JW
    Cardiovasc Res; 2019 Oct; 115(12):1791-1803. PubMed ID: 30830156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs).
    Turner NA
    J Mol Cell Cardiol; 2016 May; 94():189-200. PubMed ID: 26542796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecans in heart fibrosis.
    Lunde IG; Herum KM; Carlson CC; Christensen G
    Cell Tissue Res; 2016 Sep; 365(3):539-52. PubMed ID: 27411689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune regulation of cardiac fibrosis post myocardial infarction.
    Zaidi Y; Aguilar EG; Troncoso M; Ilatovskaya DV; DeLeon-Pennell KY
    Cell Signal; 2021 Jan; 77():109837. PubMed ID: 33207261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium.
    Dobaczewski M; de Haan JJ; Frangogiannis NG
    J Cardiovasc Transl Res; 2012 Dec; 5(6):837-47. PubMed ID: 22956156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.
    Jenke A; Schur R; Röger C; Karadeniz Z; Grüger M; Holzhauser L; Savvatis K; Poller W; Schultheiss HP; Landmesser U; Skurk C
    Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29263115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of inflammatory cells in fibroblast activation.
    Hartupee J; Mann DL
    J Mol Cell Cardiol; 2016 Apr; 93():143-8. PubMed ID: 26593723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblasts and the extracellular matrix in right ventricular disease.
    Frangogiannis NG
    Cardiovasc Res; 2017 Oct; 113(12):1453-1464. PubMed ID: 28957531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblasts in myocardial infarction: a role in inflammation and repair.
    Shinde AV; Frangogiannis NG
    J Mol Cell Cardiol; 2014 May; 70():74-82. PubMed ID: 24321195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.